The observational study, which was published in the Journal of the American Medical Association, looked at the health records of 8,709 men, of which 1,223 had testosterone therapy; the records were from 2005-2011. 26% of the testosterone therapy group suffered a heart attack, stroke or other fatal issue over the next three years while 20% of the non-therapy group suffered from the same issues.